Ethyl 2-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)acetate

Catalog No. :
ACZHCG976
CAS No. :
1126637-92-0
Molecular Formula :
C12H10F3NO2S
Molecular Weight :
289.28

IUPAC Name:Ethyl 2-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)acetate

Ethyl 2-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$637.00Login to see priceInquiryInquiry
1g97%$1274.00Login to see priceInquiryInquiry
5g97%$3732.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 2-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)acetate
IUPAC NameEthyl 2-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)acetate
Molecular FormulaC12H10F3NO2S
Molecular Weight289.28
SMILESCCOC(=O)CC1=NC2=C(C=CC(C(F)(F)F)=C2)S1
InChI KeyBFUMNEYZILZWLF-UHFFFAOYSA-N
Synonymethyl 2-(5-(trifluoromethyl)benzo[d]thiazol-2-yl)acetate;Ethyl [5-(trifluoromethyl)-1,3-benzothiazol-2-yl]acetate;2-Benzothiazoleacetic acid, 5-(trifluoromethyl)-, ethyl ester
CAS No.1126637-92-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACZHCG976 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFJG592 route compound structure diagram
    ACUFJG59213621-50-6 In Stock
  2. Plus
  3. ACQEVI674 route compound structure diagram
    ACQEVI674454-78-4 In Stock
  4. Then
  5. ACZHCG976 route product structure diagram
    ACZHCG9761126637-92-0
Inquiry

2. ACZHCG976 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACUFJG592 route compound structure diagram
    ACUFJG59213621-50-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACZHCG976 route product structure diagram
    ACZHCG9761126637-92-0
Inquiry

Comments (0)